Skip to main content
SpringerLink
Log in

Distribution of xanthine oxidase activity in a Nigerian population

  • Special Article
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Abstract

Background

Xanthine oxidase (XO) is one of the two interconvertible forms of xanthine oxidoreductase and well-studied for its role in purine catabolism and that of other purine analogues, drugs especially. Our study investigated the incidence of polymorphism in phenotypes along with the influence of gender and age on enzyme activity in a Nigerian population.

Methods

Caffeine (110 mg) was administered to each of 129 healthy, unrelated subjects who were nonsmokers. Urine voided within 7 h after dosing was collected for a high-performance liquid chromatographic analysis of metabolites, and the urinary molar ratio of metabolites was used as marker for enzyme activity. Statistical analysis of data was carried out to identify the prevalent phenotypes and also assessed the influence of age and sex on enzyme activity.

Result

A sevenfold variation in XO activity with a population mean (±SD) molar ratio of 0.43 ± 0.15 and median (interquartile range) of 0.42 (0.16) was observed. Distinctly higher enzyme activity was also recorded in 8 % of the study population, and there was no correlation (P > 0.05) between enzyme activity and the studied covariates.

Conclusions

Our study confirmed the existence of polymorphism in xanthine oxidase activity in Nigerians and also the incidence of individuals with distinctly higher XO activity in the population.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Pacher P, Nivorozhkin A, Szabo C (2006) Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol. Pharmacol Rev 58(1):87–114

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  2. Berry CE, Hare JM (2004) Xanthine oxidoreductase and cardiovascular disease: molecular mechanisms and pathophysiological implications. J Physiol 555(Pt 3):589–606

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  3. Djordjevic N, Carrillo A, Gervasini G, Jankovic S, Aklillu E (2010) In vivo evaluation of CYP2A6 and xanthine oxidase enzyme activities in the Serbian population. Eur J Clin Pharmacol 66:571–578

    Article  CAS  PubMed  Google Scholar 

  4. Landmesser U, Spiekermann S, Dikalov S et al (2002) Vascular oxidative stress and endothelial dysfunction in patients with chronic heart failure: role of xanthine-oxidase and extracellular superoxide dismutase. Circulation 106(24):3073–3078

    Article  CAS  PubMed  Google Scholar 

  5. Kudo M, Moteki T, Sasaki T, Konno Y, Ujiie S, Onose A, Mizugaki M, Ishikawa M, Hiratsuka M (2008) Functional characterization of human xanthine oxidase allelic variants. Pharmacogenet Genomics 18(3):243–251

    Article  CAS  PubMed  Google Scholar 

  6. Jack DB (1983) Statistical analysis of polymorphic drug metabolism data using the Rosin Rammler Sperling Weibull distribution. Eur J Clin Pharmacol 25:443–448

    Article  CAS  PubMed  Google Scholar 

  7. Carrillo JA, Benitez J (1994) Caffeine metabolism in a healthy Spanish population: N-acetylator phenotype and oxidation pathways. Clin Pharmacol Ther 55:293–304

    Article  CAS  PubMed  Google Scholar 

  8. Aklillu E, Carrillo JA, Makonnen E, Bertilsson L, Ingelman-Sundberg M (2003) Xanthine oxidase activity is influenced by environmental factors in Ethiopians. Eur J Clin Pharmacol 59:533–536

    Article  CAS  PubMed  Google Scholar 

  9. Saruwatari J, Nakagawa K, Shindo J, Tajiri T, Fujieda M, Yamazaki H, Kamataki T, Ishizaki T (2002) A population phenotyping study of three drug-metabolizing enzymes in Kyushu, Japan, with use of the caffeine test. Clin Pharmacol Ther 72:200–208

    Article  CAS  PubMed  Google Scholar 

  10. Djordjevic N, Carrillo JA, Roh H, Karlsson S, Ueda N, Bertilsson L, Aklillu E (2012) Comparison of N-acetyltransferase-2 enzyme genotype-phenotype and xanthine oxidase enzyme activity between Swedes and Koreans. J Clin Pharmacol 52:1527–1534

    Article  CAS  PubMed  Google Scholar 

  11. Grum CM, Ragsdale RA, Ketai LH, Simon RH (1987) Plasma xanthine oxidase activity in patients with adult respiratory distress syndrome. J Crit Care 2(1):22–26

    Article  Google Scholar 

Download references

Conflict of interest

The authors declare that they have no competing interests and source of funding.

Author information

Authors and Affiliations

  1. Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Obafemi Awolowo University, Ile-Ife, Nigeria

    Ayorinde Adehin & Oluseye Oladotun Bolaji

Authors
  1. Ayorinde Adehin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Oluseye Oladotun Bolaji
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ayorinde Adehin.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Adehin, A., Bolaji, O.O. Distribution of xanthine oxidase activity in a Nigerian population. Eur J Clin Pharmacol 71, 687–690 (2015). https://doi.org/10.1007/s00228-015-1852-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00228-015-1852-9

Keywords

Search

Navigation